| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2973024 | The Journal of Heart and Lung Transplantation | 2006 | 5 Pages |
Abstract
VAD patients with HGG are at increased risk of infections. After transplantation, these patients also experience increased cytomegalovirus infections. A randomized preemptive IgG replacement trial may be warranted in the future to determine if this intervention will alleviate the risk of infection.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mohamad H. MD, Hsuan-Hung MBBS, Volkan MD, Robin K. MD, Steven D. MD, Daniel J. PhD, Cathy RN, Kimberly RN, Tiffany RN, Robert E. MD, David O. MD, Nicholas G. MD, Randall C. MD, MPH,